These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8586134)

  • 1. Management of sleep apnoea syndrome.
    Liistro G; Aubert G; Rodenstein DO
    Eur Respir J; 1995 Oct; 8(10):1751-5. PubMed ID: 8586134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep apnoea in the older adult : pathophysiology, epidemiology, consequences and management.
    Shochat T; Pillar G
    Drugs Aging; 2003; 20(8):551-60. PubMed ID: 12795623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnoea syndrome: cardiopulmonary and diffuse manifestations.
    Lalloo MT
    Int J Clin Pract; 1998 Mar; 52(2):106-7. PubMed ID: 9624792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative and non surgical treatments for the sleep disordered breathing adult.
    Liistro G
    Acta Otorhinolaryngol Belg; 2002; 56(2):145-8. PubMed ID: 12092323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
    Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of obstructive sleep apnea.
    Kryger MH
    Clin Chest Med; 1992 Sep; 13(3):481-92. PubMed ID: 1521414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome.
    Chrysostomakis SI; Simantirakis EN; Schiza SE; Karalis IK; Klapsinos NC; Siafakas NM; Vardas PE
    Hellenic J Cardiol; 2006; 47(1):13-20. PubMed ID: 16532711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.
    Mortimore IL; Kochhar P; Douglas NJ
    Thorax; 1996 Feb; 51(2):190-2. PubMed ID: 8711654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral appliances for obstructive sleep apnoea.
    Lim J; Lasserson TJ; Fleetham J; Wright J
    Cochrane Database Syst Rev; 2003; (4):CD004435. PubMed ID: 14584014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe obstructive sleep apnoea treated with long term nasal continuous positive airway pressure.
    Frith RW; Cant BR
    Thorax; 1985 Jan; 40(1):45-50. PubMed ID: 3881841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask.
    Sullivan CE; Issa FG; Berthon-Jones M; McCauley VB; Costas LJ
    Bull Eur Physiopathol Respir; 1984; 20(1):49-54. PubMed ID: 6367865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure.
    Noseda A; Kempenaers C; Kerkhofs M; Houben JJ; Linkowski P
    Chest; 1996 Jan; 109(1):138-43. PubMed ID: 8549176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of the sleep apnea syndrome by continuous positive pressure].
    Hubert P; Meslier N; Pigeanne T; Dairien T; Racineux JL
    Rev Mal Respir; 1986; 3(3):133-8. PubMed ID: 3529262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J; Follenius M; Sforza E; Brandenberger G; Peter JD
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J; Laks L; Wilcox I; Grunstein RR; Costas LJ; McDougall JG; Sullivan CE
    Clin Sci (Lond); 1989 Oct; 77(4):407-11. PubMed ID: 2530023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nose and face mask CPAP therapy for sleep apnoea.
    Mortimore IL; Whittle AT; Douglas NJ
    Thorax; 1998 Apr; 53(4):290-2. PubMed ID: 9741373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.
    Sullivan CE; Issa FG; Berthon-Jones M; Eves L
    Lancet; 1981 Apr; 1(8225):862-5. PubMed ID: 6112294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment.
    Davies RJ; Crosby J; Prothero A; Stradling JR
    Clin Sci (Lond); 1994 Apr; 86(4):417-24. PubMed ID: 8168336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sleep apnea syndrome : multidisciplinary management. Apropos of a preliminary experience].
    Noseda A; Kempenaers C; Kerkhofs M; Hassid S; Maesen G; Ermens F; Linkowski P; Yernault JC
    Rev Med Brux; 1989 Oct; 10(8):350-7. PubMed ID: 2682915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx.
    Ryan CF; Love LL; Peat D; Fleetham JA; Lowe AA
    Thorax; 1999 Nov; 54(11):972-7. PubMed ID: 10525554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.